Reynders Mc Veigh Capital Management, LLC Crispr Therapeutics Ag Transaction History

Reynders Mc Veigh Capital Management, LLC

$1.9 Billion
Q4 2024

A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 97,687 shares of CRSP stock, worth $4.03 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

97,687

Previous 119,586 18.31%

Holding current value

$4.03 Million

Previous $5.62 Million 31.56%

% of portfolio

0.2%

Previous 0.3%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$38.65 - $55.15 $846,396 - $1.21 Million	-21,899 Reduced 18.31%	97,687 $3.85 Million
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $219,218 - $308,290	4,913 Added 4.28%	119,586 $5.62 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $905,401 - $1.21 Million	17,694 Added 18.25%	114,673 $6.19 Million
Q1 2024 May 07, 2024	BUY	$60.67 - $89.12 $5.88 Million - $8.64 Million	96,979 New	96,979 $6.61 Million
Q4 2023 Feb 07, 2024	BUY	$38.62 - $72.18 $612,899 - $1.15 Million	15,870 Added 20.83%	92,048 $5.76 Million
Q3 2023 Nov 09, 2023	BUY	$45.39 - $59.0 $1.19 Million - $1.54 Million	26,180 Added 52.36%	76,178 $3.46 Million
Q2 2023 Aug 09, 2023	BUY	$43.47 - $67.77 $1.35 Million - $2.11 Million	31,094 Added 164.48%	49,998 $2.81 Million
Q1 2023 May 03, 2023	BUY	$41.0 - $56.12 $775,064 - $1.06 Million	18,904 New	18,904 $855,000
Q3 2022 Nov 08, 2022	BUY	$61.1 - $83.78 $188,493 - $258,461	3,085 New	3,085 $202,000
Q2 2022 Aug 05, 2022	SELL	$43.23 - $73.83 $202,316 - $345,524	-4,680 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$53.19 - $79.24 $96,539 - $143,820	1,815 Added 63.35%	4,680 $294,000
Q4 2021 Feb 11, 2022	BUY	$70.09 - $111.29 $11,564 - $18,362	165 Added 6.11%	2,865 $217,000
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $10,469 - $14,880	95 Added 3.65%	2,700 $302,000
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $14,621 - $23,474	145 Added 5.89%	2,605 $422,000
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $2,214 - $4,200	20 Added 0.82%	2,460 $300,000
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $3,983 - $8,661	-50 Reduced 2.01%	2,440 $374,000
Q3 2020 Oct 28, 2020	BUY	$78.5 - $100.64 $195,465 - $250,593	2,490 New	2,490 $208,000

Others Institutions Holding CRSP

# of Institutions

488

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.22B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.

Account

Reynders Mc Veigh Capital Management, LLC Crispr Therapeutics Ag Transaction History